logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Chengqiang Li

Shanghai Jiao Tong University
H指数:19
被引数:1,408

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2)

术前pembrolizumab (anti-PD-1抗体) 联合放化疗治疗食管鳞癌1/2期临床试验 (PALACE-2)

Signal Transduction and Targeted Therapy
IF52.7
2025-11-280
OAAI
Chengqiang Li; Yichao Han; Shengguang Zhao; Xiaozheng Kang; Yuyan Zheng; Yuqin Cao; Yan Yan; Liqiang Shi; Xipeng Wang; Tong Lu; Guowen Zou; Huan Li; Jiaming Che; Jie Xiang; Lianggang Zhu; Junbiao Hang; Yajie Zhang; Runsen Jin; Dingpei Han; Xueyu Chen; Hui Jing; Wei Guo; Zenghui Cheng; Liqin Zhao; Xiaoyan Chen; Bentong Yu; Jian Li; Bin Li; Yin Li; Hecheng Li
Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)

新辅助卡瑞利珠单抗联合化放疗与观察等待策略 versus 新辅助化放疗后手术在局部晚期食管鳞状细胞癌中的应用：一项随机对照试验的研究方案（PALACE-3）

BMJ OPEN
IF2.3
2025-10-150
OA
Wang, Xipeng; Li, Chengqiang; Cao, Yuqin; Kang, Xiaozheng; Leng, Xuefeng; Zheng, Yan; Zheng, Bin; Guo, Wei; Jing, Hui; Han, Yongtao; Chen, Chun; Li, Yin; Li, Hecheng
Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy

POINT临床试验方案更新：一项多中心随机对照试验，旨在研究新辅助放化疗治疗的食管癌患者术前肠内免疫营养的影响

TRIALS
IF2
2025-10-100
OAAI
Cheng, Yumeng; Cao, Yuqin; Zhao, Shengguang; Jin, Qianwen; Li, Jian; Li, Chengqiang; Zhang, Yajie; Shen, Weiyu; He, Jinxian; Wang, Mingsong; Ji, Guangyu; Li, Zhigang; He, Yi; Chen, Qixun; Wei, Weitian; Tan, Lijie; Wang, Hao; Shi, Yongmei; Li, Hecheng
Robotic-assisted versus video-assisted lobectomy for resectable non-small-cell lung cancer: the RVlob randomized controlled trial
ECLINICALMEDICINE
IF10
2024-08-010
OAAI
Niu, Zhenyi; Cao, Yuqin; Du, Mingyuan; Sun, Siying; Yan, Yan; Zheng, Yuyan; Han, Yichao; Zhang, Xianfei; Zhang, Zhengyuan; Yuan, Ye; Li, Jian; Zhang, Yajie; Li, Chengqiang; Han, Dingpei; Du, Hailei; Guo, Wei; Chen, Kai; Xiang, Jie; Zhu, Lianggang; Che, Jiaming; Hang, Junbiao; Ren, Jian; Abbas, Abbas E.; Lerut, Toni; Lin, Jules; Jin, Runsen; Li, Hecheng
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

新辅助化疗加或不加camrelizumab治疗可切除食管鳞状细胞癌: 随机3期ESCORT-NEO/NCCES01试验

NATURE MEDICINE
IF50
2024-07-026
OAAI
Qin, Jianjun; Xue, Liyan; Hao, Anlin; Guo, Xiaofeng; Jiang, Tao; Ni, Yunfeng; Liu, Shuoyan; Chen, Yujie; Jiang, Hongjing; Zhang, Chen; Kang, Mingqiang; Lin, Jihong; Li, Hecheng; Li, Chengqiang; Tian, Hui; Li, Lin; Fu, Junke; Zhang, Yong; Ma, Jianqun; Wang, Xiaoyuan; Fu, Maoyong; Yang, Hao; Yang, Zhaoyang; Han, Yongtao; Chen, Longqi; Tan, Lijie; Dai, Tianyang; Liao, Yongde; Zhang, Weiguo; Li, Bin; Chen, Qixun; Guo, Shiping; Qi, Yu; Wei, Li; Li, Zhigang; Tian, Ziqiang; Kang, Xiaozheng; Zhang, Ruixiang; Li, Yong; Wang, Zhen; Chen, Xiankai; Hou, Zhiguo; Zheng, Rongrong; Zhu, Wenqing; He, Jie; Li, Yin
Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy)
BMC CANCER
IF3.4
2022-06-1310
OAAI
Cao, Yuqin; Han, Dingpei; Yang, Su; Shi, Yongmei; Zhao, Shengguang; Jin, Qianwen; Li, Jian; Li, Chengqiang; Zhang, Yajie; Shen, Weiyu; He, Jinxian; Wang, Mingsong; Ji, Guangyu; Li, Zhigang; He, Yi; Chen, Qixun; Wei, Weitian; Chen, Chun; Gong, Xian; Wang, Jinyi; Tan, Lijie; Wang, Hao; Li, Hecheng

研究方向

暂未获取到该数据
H
Hecheng Li
H 指数:40论文数:339被引数:6,205
Y
Yuqin Cao
H 指数:16论文数:65被引数:818
Y
Yuyan Zheng
H 指数:13论文数:50被引数:941
D
Dingpei Han
H 指数:19论文数:95被引数:1,331
Y
Yajie Zhang
H 指数:16论文数:72被引数:827
X
Xijia Feng
H 指数:8论文数:18被引数:436
R
Runsen Jin
H 指数:22论文数:122被引数:1,877
Y
Yichao Han
H 指数:15论文数:47被引数:1,579
L
Lerut, Toni
H 指数:0论文数:21被引数:20
J
Jules Lin
H 指数:48论文数:367被引数:1.4万